Found this summary on medscape.
Vedolizumab:
Gut specific biologic. Currently in phase 3. I actually called them and they told me they have no estimate as to when they will be seeking FDA approval. In the final phase of trials, so hopefully will be soon! Very effective with low side effects.
Budesonide MMX :
Enteric coated budesonide for moderate to severe left sided U.C. The last clinical trial showed that almost 50% of patients taking it were put in to remission! They are currently recruiting patients for another clinical trial. See here
clinicaltrials.gov/show/NCT01532648According to the trials so far, this drug does not suppress your adrenal system or have side effects like prednisone, and has even been shown to be effective for maintenance of remission. Of course prednisone fails on all three of those issues.
Uceris:
Another enteric coated budesonide pill. Already FDA approved and should be available this spring. For mild to moderate UC.
Tofacitinib:
Oral biologic with promising results, with up to 75% of patients showing significant improvement. Currently in late stage trials.
Two other injectable biologics are in the U.C. pipleline too, Adalimumab and Golimumab. No estimate as to when they might be available.